Clinical Trials Directory

Trials / Terminated

TerminatedNCT01907191

Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy

Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Trinity Health Of New England · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours

Detailed description

Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.

Conditions

Interventions

TypeNameDescription
DRUGliposomal bupivacaine(Ultrasound guided injection of liposomal bupivacaine) for patients undergoing hip arthroscopy
DRUGBupivacaine(around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy

Timeline

Start date
2013-07-01
Primary completion
2019-01-30
Completion
2019-01-30
First posted
2013-07-24
Last updated
2022-08-16
Results posted
2022-07-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01907191. Inclusion in this directory is not an endorsement.